PureTech Health posts half-year report update

PureTech Health plc submitted a Form 6-K as a foreign private issuer to provide investors with its half-year information package.

Rhea-AI Filing Summary

PureTech Health plc submitted a Form 6-K as a foreign private issuer to provide investors with its half-year information package. The company furnished a press release summarizing its half-year report, an interim management report and financial review for the six months ended June 30, 2025 and 2024, and unaudited condensed consolidated financial statements covering the same periods and as of December 31, 2024. These materials give a detailed update on the company’s mid-year performance and financial position, but the specific financial results are contained in the attached exhibits rather than in this cover document.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did PureTech Health plc (PRTC) file in this Form 6-K?

PureTech Health plc filed a Form 6-K furnishing its half-year report, an interim management report and financial review, and unaudited condensed consolidated financial statements.

Which periods are covered by PureTech Health plc’s half-year materials in this Form 6-K?

The interim management report and financial review cover the six months ended June 30, 2025 and 2024, and the unaudited condensed consolidated financial statements cover those six-month periods and the balance sheet as of December 31, 2024.

What exhibits are attached to PureTech Health plc’s June 2025 Form 6-K?

Exhibit 99.1 is a press release titled “PureTech Health plc – Half-Year Report,” Exhibit 99.2 is the interim management report and financial review, and Exhibit 99.3 is the unaudited condensed consolidated financial statements.

Does this Form 6-K include PureTech Health plc’s detailed financial results?

The cover document itself does not list detailed numbers; those are contained in the furnished exhibits, including the interim financial review and the unaudited condensed consolidated financial statements.

Who signed the Form 6-K for PureTech Health plc (PRTC)?

The Form 6-K was signed on behalf of PureTech Health plc by Charles Sherwood, who is the General Counsel and Company Secretary.

On what date were the attached PureTech Health plc half-year materials issued?

The press release titled “PureTech Health plc – Half-Year Report” and the accompanying materials were dated August 28, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/28/2025 - 06:47 AM Learn about SEC filing dates

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 under

the Securities Exchange Act of 1934

For the month of June 2025

Commission File Number 001-39670

PURETECH HEALTH PLC

(Translation of registrant’s name into English)

6 Tide Street, Suite 400

Boston, Massachusetts 02210

(Address of principal executive offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F  ☒                Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  o

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  o

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

On August 28, 2025, PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) (the “Company”) issued a press release containing its half-year report and associated interim financial review and financial statements.

The press release is furnished herewith as Exhibit 99.1, the interim management report and financial review for the six months ended June 30, 2025 and 2024 are furnished herewith as Exhibit 99.2, and the unaudited condensed consolidated financial statements as of and for the six months ended June 30, 2025, and 2024, and as of December 31, 2024, are furnished herewith as Exhibit 99.3.

Exhibits

99.1						Press Release of PureTech Health plc, dated August 28, 2025, titled "PureTech Health plc – Half-Year Report"
99.2						Interim Management Report and Financial Review for the Six Months Ended June 30, 2025 and 2024
99.3						Unaudited Condensed Consolidated Financial Statements as of and for the Six Months Ended June 30, 2025 and 2024 and as of December 31, 2024

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

			PURETECH HEALTH PLC
Date: August 28, 2025			By:			/s/ Charles Sherwood
			Name:			Charles Sherwood
			Title:			General Counsel and Company Secretary